MedPath

Levocarbdin

Brand Name: Levocarbdin

Generic Name: Levodopa + Carbidopa

Active
Registration Number

DRP-7708-01

Dosage Form

Tablet

Issuance Date

September 1, 2022

Expiry Date

February 26, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg/ 25 mg
PackagingPVC/Alu Blister Pack x 10's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiparkinson (Dopaminergic)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

LevodopaActive
Monograph: Levodopa
CarbidopaActive
Monograph: Carbidopa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform